True Light Capital

True Light Capital is a Singapore-based private investment firm that employs a theme-driven approach to invest across various asset classes, sectors, and stages. The firm is a wholly-owned subsidiary of Temasek Holdings, a Singaporean government-owned investment company. True Light Capital's investment strategy is characterized by flexibility and opportunism, allowing it to adapt to evolving market conditions and identify opportunities that align with its thematic focus. The firm has a global investment horizon, with interests spanning multiple continents, including Asia, North America, and Europe. This broad geographical focus enables True Light Capital to leverage diverse market dynamics and access a wide range of investment opportunities. The firm's portfolio encompasses a variety of industries, reflecting its commitment to thematic investing. Notable sectors include healthcare, biotechnology, technology, consumer goods, and financial services. This diversified industry focus allows True Light Capital to capitalize on emerging trends and innovations across different markets. True Light Capital's investment approach is characterized by a combination of private equity and venture capital strategies. The firm engages in investments at various stages, from seed and early-stage ventures to growth and late-stage companies. This multi-stage investment capability enables True Light Capital to support businesses throughout their lifecycle, from inception to maturity. The firm's recent investments include a significant stake in OTR Therapeutics, a Shanghai-based biotechnology company focused on transforming early scientific discoveries into globally relevant therapies. In June 2025, True Light Capital led a $100 million Series A funding round for OTR Therapeutics, highlighting its commitment to advancing innovative healthcare solutions. This investment underscores True Light Capital's strategic focus on the healthcare and biotechnology sectors, aligning with its thematic investment approach. The firm's involvement in OTR Therapeutics also reflects its dedication to supporting companies that aim to address significant medical needs through innovative research and development. True Light Capital's investment philosophy emphasizes a long-term perspective, seeking to create value by partnering with companies that demonstrate strong growth potential and a commitment to excellence. The firm's global presence and diverse industry focus position it to make strategic investments that contribute to the advancement of various sectors and the realization of its thematic investment objectives.

In summary, True Light Capital is a dynamic private investment firm that leverages its thematic investment approach to identify and support opportunities across a wide range of asset classes, sectors, and stages. Its global investment strategy, combined with a diversified industry focus, enables the firm to adapt to changing market conditions and invest in companies with strong growth potential. Through strategic investments like its stake in OTR Therapeutics, True Light Capital demonstrates its commitment to advancing innovative solutions in healthcare and biotechnology, reflecting its broader investment philosophy and objectives.

The firm's affiliation with Temasek Holdings provides it with a robust financial foundation and access to a vast network of resources, enhancing its ability to execute its investment strategy effectively. True Light Capital's approach to investing is characterized by thorough due diligence, a focus on value creation, and a commitment to fostering long-term partnerships with portfolio companies. This approach ensures that the firm can navigate complex markets and contribute meaningfully to the success of the businesses it invests in.

Overall, True Light Capital exemplifies a modern investment firm that combines strategic insight, financial acumen, and a global perspective to achieve its investment goals and support the growth of its portfolio companies.